Myopia

5 trials 2 recruiting MedDRA PT
5 Registered trials
2 Recruiting
5 Unique sponsors
4 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
S Ophthalmology/ENT (ATC S) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Phase III: 3 Phase II: 2

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase III

3 trials
  • Ocumension (Hong Kong) Ltd. Commercial
    ATROPINE SULFATE
    2024-516315-24-00 5 countries 2022 n=210
    Ended
  • Ocus Innovation Ireland Limited Commercial
    ATROPINE SULFATE MONOHYDRATE
    2023-510439-13-00 3 countries 2025 n=137
    Recruiting
  • Sydnexis Inc. Commercial
    ATROPINE SULFATE MONOHYDRATE
    2023-509134-19-00 2 countries 2019 n=70
    Ended

Phase II

2 trials
  • Laboratoires Thea Commercial
    SODIUM PHENYLBUTYRATE
    2025-521563-13-01 1 country n=20
    Pending
  • Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal Academic
    BRIMONIDINE TARTRATE
    2025-521878-33-00 1 country 2025 n=40
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Laboratoires Thea Commercial 1 Phase II 0
Ocumension (Hong Kong) Ltd. Commercial 1 Phase III 0
Ocus Innovation Ireland Limited Commercial 1 Phase III 1
Sydnexis Inc. Commercial 1 Phase III 0
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal Academic 1 Phase II 1
New trials by year
2019
1
2022
1
2025
2
← All indication landscapes